Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?-Reference-Cited by-同舟云学术

Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?

Published:2010-04-19 Issue:6 Volume:6 Page:761-771
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Kirwan Chris,MacPhee Iain,Philips Barbara

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2010.482929

Reference99 articles.

1. Case mix, outcome and activity for patients with severe acute kidney injury during the first 24 hours after admission to an adult, general critical care unit: application of predictive models from a secondary analysis of the ICNARC Case Mix Programme Database

2. Drug-Associated Disease: Cytochrome P450 Interactions

3. Ertapenem clearance during modeled continuous renal replacement therapy

4. Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury

5. Pharmacokinetic issues for antibiotics in the critically ill patient

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraindividual Variability in Absolute Bioavailability and Clearance of Midazolam in Healthy Individuals;Clinical Pharmacokinetics;2023-05-10

2. Assessment of Pharmacokinetic Drug–Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited;Annual Review of Pharmacology and Toxicology;2019-01-06

3. Recovery of CYP3A Phenotype after Kidney Transplantation;Drug Metabolism and Disposition;2017-09-19

4. Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome;Drug Metabolism and Disposition;2017-03-02

5. Xenobiotic Metabolism: The Effect of Acute Kidney Injury on Non-Renal Drug Clearance and Hepatic Drug Metabolism;International Journal of Molecular Sciences;2014-02-13